Skip to main content
. 2021 Feb 1;2021:8825374. doi: 10.1155/2021/8825374

Figure 6.

Figure 6

Effect of antitumor necrosis factor- (TNF-) α agents on serum leucine-rich alpha-2 glycoprotein (LRG) levels in the patients with ulcerative colitis and those with Crohn's disease. For each disease, patients were divided into two treatment-based subgroups: patients taking anti-TNF-α agents and patients receiving any other medication. The bars indicate the median ± 25th percentile. The lower bar indicates the 10th percentile, and the upper bar indicates the 90th percentile.